U.S. Construction Stock News

Capricor Therapeutics (CAPR) recently drew investor attention after presenting Phase 3 HOPE-3 data for Deramiocel in Duchenne muscular dystrophy at the 2026 American Academy of Neurology meeting, alongside an ongoing Biologics License Application review. See our latest analysis for Capricor Therapeutics. The latest HOPE-3 data and ongoing BLA review have arrived alongside strong momentum, with a 30 day share price return of 17.96%, a 90 day share price return of 52.03% and a very large 3 year...

Maze Therapeutics (NasdaqGM:MAZE) completed a sizable underwritten public offering of common stock and pre funded warrants. The deal drew significant participation from both new and existing institutional investors. Proceeds are earmarked to advance Maze Therapeutics' research and development programs focused on serious diseases. Maze Therapeutics, trading at a recent share price of $25.81, has experienced sharp share price swings, with a 7 day return of an 8.1% decline and a 30 day return...

Earlier this week, Futu Holdings’ platform moomoo launched Moomoo API Skills, allowing retail investors to link their personal AI agents to moomoo’s professional-grade trading infrastructure and convert natural language instructions into executable, but still manually authorized, investment strategies. This move highlights how Futu is deepening AI integration across its ecosystem, potentially reshaping user engagement by automating complex, around-the-clock investment workflows without...

Tompkins Financial (TMP) opened 2026 with Q1 results that build on a strong finish to 2025, with trailing 12 month revenue of US$435.1 million and basic EPS of US$11.30 supported by Q4 2025 net income of US$96.2 million on revenue of US$193.8 million. Over the past year, revenue has moved from US$292.6 million to US$435.1 million on a trailing basis while basic EPS climbed from US$4.98 to US$11.30, alongside net profit margin at 37% versus 24.2% the prior year. This sets up a quarter where...

Corcept Therapeutics (CORT) is back in focus after securing FDA approval for Lifyorli in platinum-resistant ovarian cancer and scheduling Phase 3 ROSELLA data for an oral presentation at the 2026 ASCO Annual Meeting. See our latest analysis for Corcept Therapeutics. With Lifyorli’s FDA approval and the upcoming ROSELLA Phase 3 presentation in view, Corcept’s 30-day share price return of 13.81% and year-to-date share price return of 20.58% contrast with a 1-year total shareholder return of...

Dime Community Bancshares (DCOM) is back in focus after its first quarter 2026 earnings release, where revenue and several core banking metrics moved ahead of market expectations despite a modest earnings per share shortfall. See our latest analysis for Dime Community Bancshares. The earnings beat on revenue and banking metrics has come alongside a 1 month share price return of 5.91% and a year to date share price return of 18.15%. The 1 year total shareholder return of 42.34% and 3 year...

LPL Financial Holdings (LPLA) recently reported a cybersecurity incident involving unauthorized securities trades and fund transfers in some client accounts, prompting questions about operational risk and potential implications for the stock. See our latest analysis for LPL Financial Holdings. At a share price of US$320.51, LPL Financial has seen a 6.6% 1 month share price return but a 90 day share price decline of 11.5%. The 5 year total shareholder return of 109.6% points to stronger longer...

Revolution Medicines (NasdaqGS:RVMD) reported preclinical data for RM-055, a new class of catalytic RAS(ON) inhibitors that convert oncogenic RAS to an inactive state in multiple cancer models. The company also shared updated first line clinical data for daraxonrasib in untreated metastatic pancreatic cancer, supporting further Phase 3 evaluation. These announcements expand beyond prior late stage updates that focused on second line pancreatic cancer data and related financings. For...

SolarEdge Technologies (SEDG) is back in focus after launching its CSS-OD 197 kWh commercial storage system for Europe and Asia, while traders also watch the stock ahead of early May earnings. See our latest analysis for SolarEdge Technologies. Recent trading has been choppy, with a 19.66% 7 day share price return, a 30 day share price decline of 10.63%, and a 46.14% year to date share price gain, alongside a very large 1 year total shareholder return and deeply negative 3 and 5 year total...

Recent share performance and business scale Hercules Capital (HTGC) has seen mixed share performance recently, with a gain over the past month but a decline in the past 3 months and year to date, leaving the stock around $15.51. The company operates as a business development company focused on venture debt and growth capital. It reports about US$532.493 million in revenue and US$337.025 million in net income, with annual growth reported in both measures. Hercules Capital reports a market...

Patrick Industries (NasdaqGS:PATK) is reportedly in active merger talks with LCI Industries about a potential all stock combination. The discussions, if successful, could create a larger supplier focused on recreational vehicle components and related products. An announcement could be made soon, although no definitive agreement has been disclosed. Patrick Industries supplies components and building products primarily to the recreational vehicle sector, as well as to adjacent markets such as...

TeraWulf Inc. has recently closed an upsized public offering of 54,510,000 common shares at US$19.00 each, raising roughly US$900.6 million to help fund its planned Hawesville, Kentucky data center campus, repay a bridge credit facility, and support future site acquisitions and general corporate uses. This capital raise, executed under an omnibus shelf registration and backed by a syndicate led by Morgan Stanley, signals a move to scale TeraWulf’s digital infrastructure footprint while...

Molson Coors Beverage (TAP) is back in focus after recent share price swings, with the stock showing mixed short term performance and a weaker past year. This has prompted investors to revisit its current fundamentals. See our latest analysis for Molson Coors Beverage. Recent trading has been choppy, with a 1 day share price return of negative 1% and a 7 day share price return of negative 4.82%. The 1 month share price return of 2.83% contrasts with a 90 day share price return of negative 14%...

Diana Shipping has publicly accused Genco Shipping & Trading (NYSE:GNK) of delaying its shareholder vote and using entrenchment tactics. The dispute centers on the timing of Genco’s annual meeting and how shareholder proposals, including board changes, are being handled. This escalation in the proxy contest raises questions about future control and governance at the dry bulk carrier. Genco Shipping & Trading, listed on the NYSE as GNK, operates a fleet of dry bulk vessels that move...

Hormel Foods has completed the sale of its whole-bird turkey business to Life-Science Innovations, transferring the Melrose, Minnesota production facility, feed mill, and transportation assets, while retaining the JENNIE-O brand and value-added turkey operations. This carve-out leaves Hormel with the higher-margin, branded and processed side of its turkey portfolio, while exiting more commodity-oriented whole-bird production. Next, we’ll examine how retaining JENNIE-O’s value-added turkey...

Wondering whether Array Technologies at US$8.11 is offering value or just noise? This article walks through what the current price might be saying about the stock. Over the short term, the share price move of 3.6% over 7 days and 4.9% over 30 days sits alongside a 16.2% decline year to date and a 61.6% return over the last year. Taken together, this gives you a very mixed picture. These moves come as Array Technologies continues to sit in a solar and renewables theme that regularly attracts...

Iridium Communications Inc. has reported past first‑quarter 2026 results, with revenue rising to US$219.06 million while net income and earnings per share declined year on year. Management reaffirmed its outlook for flat to 2% full‑year 2026 service revenue growth despite profit pressure from a revised compensation structure and softer margins. Next, we’ll examine how reaffirmed 2026 guidance amid weaker profitability reshapes Iridium’s existing investment narrative and its key growth...

Wondering if Comcast at around US$27.56 is a potential bargain or a value trap? This article breaks down what the current price really implies for you as a shareholder. The stock has seen pressure recently, with returns of a 7.0% decline over 7 days, a 4.0% decline over 30 days, and a 6.7% decline year to date, while the 1-year and 5-year returns stand at a 9.4% decline and a 38.9% decline. Recent coverage of Comcast has focused on the business as a core telecom and media player, with...

Earlier this week, Elevance Health reported first-quarter 2026 results with revenue of US$50.18 billion and net income of US$1.76 billion, while also declaring a second-quarter dividend of US$1.72 per share and updating full-year 2026 diluted EPS guidance to at least US$19.85. Beneath the headline numbers, the quarter featured earnings that exceeded analyst expectations, a higher adjusted EPS outlook, and ongoing support from share repurchases that reduced the share count by 3,700,000 in the...

Ralliant (RAL) has drawn attention after recent trading left the shares about 1.7% lower on the day and roughly 5.8% lower over the past week, despite a small gain over the past month. See our latest analysis for Ralliant. Zooming out, the share price return shows pressure over the past quarter and year to date, with the 30 day share price return of 4.32% not yet offsetting a 16.94% three month share price decline and 12.87% year to date share price decline. If this kind of uneven momentum...

Agnico Eagle Mines agreed to acquire B2Gold's 70% interest in the Fingold joint venture, expanding its ownership position in that project. The company also announced a separate deal to acquire all shares of Rupert Resources, adding another gold-focused asset to its portfolio. These transactions represent a material expansion of NYSE:AEM's project pipeline and mark a shift from the recent focus on earlier exploration efforts. NYSE:AEM recently closed at $200.23, with the share price up 17.5%...

If you are wondering whether IAC is attractively priced or if the recent buzz is already reflected in the share price, this article walks through the key signals that matter for valuation focused investors. IAC shares last closed at US$44.48, with returns of 0.3% over 7 days, 11.5% over 30 days, 13.9% year to date and 25.1% over 1 year, compared with a much weaker 3 year return of 4.3% and a 5 year return showing a 68.0% decline. Recent headlines around IAC have kept attention on how the...

Rivian Automotive (RIVN) has kicked off production of its R2 electric SUV at its Normal, Illinois, plant, keeping the launch timeline on track even after tornado damage to part of the facility. See our latest analysis for Rivian Automotive. The recent launch of the R2 line and Rivian’s focus on software and battery partnerships have come alongside a 5.76% 1 month share price return and a 30.90% 1 year total shareholder return. However, a year to date share price performance of negative 14.89%...

In recent days, Goldman Sachs upgraded Par Pacific Holdings, Inc. to Buy from Neutral and JPMorgan reaffirmed its positive stance, highlighting the company’s earnings strength in Hawaii and the potential of its mainland refining assets across the Pacific and Rocky Mountain regions. The analysts’ renewed focus on Par Pacific’s exposure to fuel markets linked to Singapore tightness underscores how regional supply imbalances can materially influence this diversified refiner’s earnings...